After declaring aducanumab a failure, the manufacturer now says the drug may help slow cognitive decline in certain patients. Some experts are skeptical.
Published: October 22, 2019 at 10:48PM
from NYT Health https://ift.tt/2MZm4JG
After declaring aducanumab a failure, the manufacturer now says the drug may help slow cognitive decline in certain patients. Some experts are skeptical.
Published: October 22, 2019 at 10:48PM
from NYT Health https://ift.tt/2MZm4JG